Nykode Therapeutics
NYKD.OL
#9614
Rank
A$0.16 B
Marketcap
A$0.41
Share price
-2.56%
Change (1 day)
26.73%
Change (1 year)

Earnings for Nykode Therapeutics (NYKD.OL)

Earnings in 2026 (TTM): -A$35.69 Million

According to Nykode Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$26.55 Million, an increase over its 2024 earnings that were of -A$68.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nykode Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$35.69 Million34.41%
2025 -A$26.55 Million-61.22%
2024 -A$68.46 Million3.3%
2023 -A$66.27 Million-14.68%
2022 -A$77.67 Million366.45%
2021 -A$16.66 Million